A Phase 2, Randomized, Double-blind, Placebo controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma

Project: Research

Project Details

StatusActive
Effective start/end date19/07/24 → 18/07/26

Keywords

  • Clinical Trials
  • 20220093